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Compartmentalized redox faults are common to ageing diseases. Dietary constituents are catabolized to NAD(H) donating
electrons producing proton-based bioenergy in coevolved, cross-species and cross-organ networks. Nicotinamide and NAD
deﬁciency from poor diet or high expenditure causes pellagra, an ageing and dementing disorder with lost robustness to infection
andstress.NicotinamideandstressinduceNicotinamide-N-methyltransferase(NNMT)improvingcholineretentionbutconsume
methyl groups. High NNMT activity is linked to Parkinson’s, cancers, and diseases of aﬄuence. Optimising nicotinamide and
choline/methyl group availability is important for brain development and increased during our evolution raising metabolic and
methylome ceilings through dietary/metabolic symbiotic means but strict energy constraints remain and life-history tradeoﬀsa r e
the rule. An optimal energy, NAD and methyl group supply, avoiding hypo and hyper-vitaminoses nicotinamide and choline, is
importantto healthyageing andavoids utilisingdouble-edged symbiontsoruncontrolled autophagy orreversionstofermentation
reactions in inﬂammatory and cancerous tissue that all redistribute NAD(P)(H), but incur high allostatic costs.
1.Introduction
“Progress engenders Leisure whereby Energy is
directed toward advancement of the Mind in
all parts of Society that in turn receives new
Energy.” Turgot, 1750.
“In my theory there is no absolute tendency
to Progress, except from favourable Circum-
stances” Darwin, 1838.
Mental and neurological disorders are poorly explained
yet constitute a good proportion of the global burden of
disease, now deﬁned as the inability to adapt homeostatically
in the face of social, physical, and emotional challenges
[1–3]. Robust brain development in the ﬁrst place must
help and is deﬁned by environmental factors and cell types
that evolve in a series of networks to ensure the eﬃcient
ﬂow of energy and information [4–6]. Energy supplies
from food are a prerequisite for producing the necessary
variety of cells and simultaneously act as a major selection
force inﬂuencing their survival; yet despite its importance
to brain evolution and development inequalities of diet,
particularly over meat and caloriﬁc intake, remain a global
issue, as do stress responses such as overeating [7–11].
Bidirectional circuits, from the energy supply to terminal
ﬁelds, are selected from early exuberant developmental
(but evolutionarily constrained) ﬁelds by environmental
exposures but must have weak links as strong safety factors
against every eventuality whether environmental, genetic
or stochastic would be too expensive in energy terms. At
risk circuits may include cholinergic, serotoninergic, and
dopaminergic systems that have not scaled up as fast as
the overall three-fold expansion of the brain in the human
primate [12–20].
Redox energetic faults and aberrant mitochondrial
dynamics with consequent oxidative stress, and loss of2 Current Gerontology and Geriatrics Research
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Figure 1: NAD(H)—the electron donor to complex I translocating protons across the membrane by a “steam engine” like mechanism
producing ATP: the most important function of mitochondria alongside proton leaks for heat and energy dissipation and signals
for autophagy and apoptosis. Many mutations that aﬀect mitochondrial complex 1, or, microtubular function and kinases and
autophagy/mitophagy and radical production contribute to rare forms of ageing diseases such as PD in a vicious cycle subverting normal
quality controls that aﬀect proteosomal homeostasis. In the case of Parkinsons’, increasing NADH levels may drive excessive dopamine
synthesis to toxic levels by enhancing the recycling of the cofactor for tyrosine hydroxylase.
calcium, glutamate, proteosome, and inﬂammasome home-
ostasis are important proximate mechanisms of acute and
chronic diseases and the physiological declines that are
linked to ageing [21–31]. Some of these disease circuits may
have particularly high energy requirements, for instance,
those aﬀecting higher intellectual and complex physi-
cal exploratory or reward functions using cholinergic or
dopaminergic neurons: these for instance have mechanisms
of autonomous pace-making with a high metabolic energy
costin terms of ATP to maintain tight controlof intracellular
calcium and complex redox needs involving cofactors, met-
als, and melanin [21, 32]. Conﬁrmation of this fundamental
and compartmentalized failure of the energy supply, often
with impaired autophagy and mitophagy, comes from study
of acute brain injury from hypoxia or hypoglycaemia or
direct trauma, mitochondrial mutations linked with chronic
diseases of ageing such as Alzheimer’s (AD), Parkinson’s
(PD)andHuntington’sDisease,and,Complex1toxins(such
as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP))
or rotenone and physical tests of endurance such as polar
and high altitude expeditions [33–40]. The root cause of
these diseases may be exposed energy and informatic links
and responses with inadequate redox and mitochondrial
potentials aﬀecting proton based power and available ATP.
Levels of cellular ATP aﬀect all processes from muscle
contraction to repolarization of neuronal membranes, to
synthesis of cellular building blocks, to protection against
microbes and toxins, and maintenance of proteins, RNA,
DNA, and chromatin [41–44].
N o wi sa na p p r o p r i a t et i m et ol o o ka tt h ee ﬀects of
energy and the interlinked nicotinamide and methyl-group
under and oversupply and their relationships to information
transfer and work outputs including those done to improve
personal niche environments and evolutionary processes
[45, 46]. This survey includes a historical episode when the
nicotinamide, and tryptophan and hence NAD(P) supply
(and potentially over 400 dependent reactions that inﬂuence
every area of metabolism) failed as did the supply of methyl-
groups. The forgotten case of the complex socioeconomic
disease, Pellagra, may be a lesson about losing energy and
redox “logic” at several hierarchical levels, and we intend to
show that there may be current scope to adjust the dose of
the macro- and micronutrients involved, across and within
populations and according to individual need, aiming to
improve robustness and resilience to a range of degenerative
and proliferative diseases [47–49].
Background(1):AgeingDiseases,Evolution,andNADH. Cur-
rent theories on ageing, lifetime behaviour patterns, repro-
ductive cycles, intergenerational transfer of resource and
stress responses invoke energy sources, sensors, regulators
and tradeoﬀs: as do wider theories on the astonishingly rapid
metabolic evolution of big brains aided by the ecological,
social, and cultural strategies used by man that aﬀect
both access to energy useful information and increase in
net energy input and allocation of energy resources [50–
58]. Thermodynamically open and phylogenomic models
support the idea that NADH and nicotinamide adenine
dinucleotide phosphate (reduced) (NADPH) havehad a cen-
tral role and are the common currency in linking circadian
environments to mitochondrial metabolism and vice versa
[59–66]( Figure 1). Sharing hydrogen and its carrier aroundCurrent Gerontology and Geriatrics Research 3
Nicotinamide and NAD(H) interactions with cellular processes
DNA modulation
Apoptosis
Apoptosis
Histone and nuclear
protein modiﬁcation
cADP ribose
Neuronal
signalling 
Intracellular
Chemotaxis
Nicotinamide
NADP(H)
Sirt2
NAD(H)
CD38
PARP
ART2
FOXO transcription factors and
histone deacetylation
ADPR protein
Antioxidant
defences
Antioxidant
defences
CD 38
inhibition
{TNF and E2
regulation of expression}
Ca2+ regulation
Figure 2: Direct redox regulation apart NAD-consuming pathways inﬂuences a prodigious number of pathways involved in internal
metabolism and connections with the external world. Survival at the cellular level and of viable interactions with each other and diet and
symbionts means that NAD and Nicotinamide are at the hub of the survival of superorganisms such as ourselves. Key: FoxO—forkhead
transcription factors; Sirt2 and PARP in text; CD38 cluster diﬀerentiation 38; TNF—tumor necrosis factor; E2 Prostaglandin E2; cADP—
cyclic adenosine di-phosphate; ART2—T-cell ADPribosyltransferase; ADPR protein—adenosine di-phosphate ribose protein.
equitably as the source of electrons is complex relative to
the supply of the electron acceptor oxygen that is free, but
when successful enables eﬃcient energy ﬂows to be achieved:
there is some danger from free radical damage from oxygen
metabolism, though a prime importance of this for ageing
is now in some dispute with the spotlight now on NAD
and nicotinamide [67]. Eﬃcient energy conservation in turn
allowed the evolution of complex ecosystems and the expan-
sion of genetic and species diversity, including the develop-
ment of socially interacting brains working vertically down,
up, and across generations often through NAD-dependent
neuroendocrine and neurotransmitter mechanisms [68–76].
Recent reviews on nicotinamide and NAD metabolism,
evolution and function concentrate on its pivotal role in
gene silencing, development and ageing, through recently
appreciated NAD consumers, such as the sirtuins (SIRTs)
[77–85], that evolved to work in large part as nutrient-
sensing regulators, and poly (ADP ribose) polymerases
(PARPs) [86, 87] and on the role of NAD(H) in Wallerian
degeneration and neuronal death after a variety of insults
[88, 89]( Figure 2). These reviews do not do justice to
the importance of nutritional and symbiotic interfaces or
the developmental dynamics of inducing NNMT, which
partly regulates NAD(H) via controlling and detoxifying
the supply of nicotinamide (vitamin B3), at the cost of
losing S-adenosyl-methionine (SAM), the only metabolic
methyl donor, or the related role of evolutionary history
as the ultimate basis for understanding the proximate
pathophysiology of a range of modern diseases [90–96].
Background (2): Symbiotic Energy Environments. Flow of
energy largely determines the structure of ecosystems via
food webs and taste sensors with appetite and quality
controls, that avoid toxins but allows self-medication, and
involve ATP sensitive autophagy in hypothalamic neurones
[97–99]. Diet with concurrent domestication of microbes
as gut symbionts (or yeasts to ferment foodstuﬀs) that
break down proteins or indigestible starches or manufacture
vitamins, including nicotinamide, has evolved to supply and
translocate energy and information via circadian pulses of
NAD(H): particular symbionts, for example, buﬀer particu-
lar diets such as those low in meat and dairy consumption or
high in plant based carbohydrates [100, 101]. Disturbance
of these symbiotic relationships, such as by the over-
use of antibiotics, is receiving considerable attention in
several conditions that are increasing in incidence currently
[102]. Swopping production of vitamins and some catabolic
enzymes from personal metabolism to diet or symbionts
appears to help ﬁnd hydrogen-based energy [103]. Diets
(that both depend on and have shaped cultural niche
constructions, such as farming selected crops, domestication
of animals for milk and meat, and cooking) and the
entangled symbionts which form the microbiome in the
gut are essential synergies for the evolution of human
life and energy harvesting directly through NADH/ATP
production [104, 105]. Diet and symbionts compensate for
each other by acting as coupled recycling systems at many
metabolic, immunologic, and behavioural levels, and both
are implicated when energy balances go wrong as in the case4 Current Gerontology and Geriatrics Research
of obesity, and when both are insuﬃcient, gut cells may even
break down their own components to obtain energy [106–
111].
Failure of the supply of NAD(H) as a consequence
of malnutrition or starvation triggers other attempts to
compensate by autocarnivory to avoid apoptosis or necrotic
cell death, particularly important for neurones and other
cells that are rarely renewed after birth [112, 113].
Immune/inﬂammasomemodulationwithsuchmalnutrition
also occurs and allows the organism to tolerate microorgan-
isms which are potentially deleterious but are also capable
of supplying NAD(H) or its precursors [114]. Reversion
to fermentation occurs in inﬂamed or cancerous tissue,
favouring net NADH export (the Warburg phenomenon)
and interacts with autophagic mechanisms with recruitment
of somatic oncogene mutations and methyl-group sensitive
epimutations to achieve this metabolic milieu [115–119].
All the above may be homeostatic short-term attempts to
correct a poor local energy/redox environment whether by
producing, redistributing, or wasting energy to heat. As
another redistributive example, ectopic fat stores, which
include uncoupling proton-wasting inﬂammatory sites with
lossofmitochondrialpotential,arepartofthemetabolicsyn-
drome to which populations that have recently undergone a
nutrition transition are especially prone [120–123].
2.Pellagra
An NAD(H) deﬁciency state that illustrates the complexity
of these coevolved energy networks was observed during
the largely forgotten epidemics of pellagra caused by eco-
nomically determined suboptimal foraging of nicotinamide
and tryptophan (tryptophan is converted to NAD and
serotonin) and dietary sources of methyl-groups. Such a
dietary deﬁciency may still be important in sections of mod-
ern populations and intracellular and microenvironmental
deﬁciency states can also occur from high NAD expenditure
with NAD(H) ratios also aﬀected by any disorder that causes
hypoxia or hypoglycemia [124, 125].
2.1. Clinical Features of Pellagra. Scientiﬁc detectives investi-
gating ageing diseases and human evolution should revisit a
fork in the intellectual road that happened exactly a century
ago for real-life ecological rather than solely laboratory-
based clues around the NADH-NAD consumer axis (that
are often controversial due to confounding factors in exper-
imental design that try too hard to separate physiological
homeostasis and stress responses from ageing or are too
genecentric given that most genes in some ecological context
o ro t h e rh a v es u r v i v a lv a l u e )[ 126–141]. Then the last
major epidemic in man occurred (pellagra also occurs in
several other carnivorous species such as dogs) with a
systems failure of NAD(H) and therefore thermodynamic,
NAD-Hub, and methylome homeostasis at all hierarchical
levels. The epidemic started and ended socioculturally.
Hypovitaminosis B3 caused a premature ageing condition
with loss of robustness to chemical, physical, and emotional
stress, leading to parkinsonism, dementia, metabolic disease,
and cancer. It was conquered by dietary supplementation.
Famously, pellagra caused dementia, a characteristic photo-
sensitive dermatitis (Casal’s necklace), diarrhea, and death.
The cause was real world economics creating NAD(H)
gradients across poor populations, and across sexes (as it
was twice as common in women) in the cotton- and corn-
dependent states of the southeastern USA that reached
epidemic proportions. Too much corn and molasses and
too little meat led to a diet deﬁcient in nicotinamide and
probably other vitamins such as riboﬂavin and choline but
often adequate or even high in calories. Currently a similar
situation exists in parts of Africa. In the USA, familial
aggregations were common, suggesting genetic predisposing
factors and widespread epigenetic reprogramming. A diet
with too much corn and too little meat caused deﬁciencies
of nicotinamide and the essential amino acid tryptophan,
though deﬁciencies in other vitamins, such as choline, and
other methyl donors contributed to the malaise. Mental
symptoms were wider than dementia, in that depression,
fatigue, psychomotor retardation, mania, obsessions, and a
whole range of psychoses with auditory and visual halluci-
nations were well described, along with personality change
and sociopathic and drug and alcohol addictive behaviours.
Panic disorders were seen as was a general inability to deal
with physical or mental stress. Poor brain development such
as hydrocephalus or cerebral palsy was also common. Acute
delirium or even coma occurred, with some patients having
myoclonus and other extrapyramidal signs reminiscent of
the spongiform encephalopathies. The dementias of pellagra
includedfeaturesakintoLewybody,Alzheimer’s,frontotem-
poral, vascular, and prion diseases. Parkinsonism was also
commonandafestinantgaitwasﬁrstdescribedinpellagrins.
Tremors of various descriptions, including asymmetric rest
tremors, were noted and some patients had typical paralysis
agitans. Pellagrins had a characteristic expressionless facies,
so some signs of parkinsonism were present in most cases.
Many features of pellagra closely resemble the nonmotor
aspects of PD.
The neurological manifestation did not stop there
because other degenerative conditions, such as an amy-
otrophic lateral sclerosis-like picture, were described, with
fasciculation of the tongue and upper and lower motor
neuron signs. Cerebellar syndromes occurred and vertigo
was frequent. Headaches, sensory and pain syndromes,
epilepsy, and involuntary movements were noted as well as
sleep disturbances. Cord lesions were also seen, as was optic
atrophy, so there were multiple sclerosis (MS), like variants.
Non-neurological eﬀects included the diagnostic photo-
sensitive and ageing dermatitis along with diarrhea from
multiple gut infections. Other infections including tubercu-
losis (TB) were common, suggesting a widespread eﬀect on
the immune system. There were also profound metabolic
eﬀects on the endocrine and thermoregulatory systems. For
instance, endocrine dysfunction in thyroid and cortisol and
reproductive pathways were all clearly described. Cancer
rates were increased but masked by a high premature death
rate.
Pellagra without dermatitis was well accepted and a
frequently overlooked diagnosis. Young men from aﬀected
states had inordinate diﬃculty in passing the intellectualCurrent Gerontology and Geriatrics Research 5
tests that involved reading, writing and numeracy skills and
the physical ﬁtness tests required by the military, suggesting
that subclinical disease was rife. Indeed poor diet and health
have been implicated in the Southern states both having
a tradition of violence (particularly toward the stealing of
nicotinamide-rich livestock) and losing the American Civil
War [142].
The classic pathological sign was chromatolysis of the
high energy requiring pyramidal cells in the cortical gray
matter but Purkinje cells also degenerated and there was
a widespread cell loss in basal and sympathetic ganglia.
Demyelination was commonly seen in the spinal cord,
particularly in the posterior and lateral columns. Much
was made of pigmentary change, glial overgrowth, vascular
change, amyloid deposition, cytoskeletal and mitochondrial
abnormalities and signs of inﬂammation and atrophy in all
organs. A systems failure with the degenerative pathology of
precocious senility was proposed by several pathologists in
the late 19th century, and clinicians commented on patients
as “wrecks of humanity”.
Pellagra is a wide systems failure in that an ecologic
dietary stress triggers developmental and degenerative eﬀects
aﬀecting behaviour and a vicious cycle which ampliﬁed the
original economic stress. In addition, healthy members of
society were phobic about pellagrins and showed them little
if any empathy (unlike most other disabilities) and preferred
explanations, such as a poor gene pool or that they were
infectious, rather than blaming poverty. This picture, we
suggest, may represent some aspects of human evolution
gone wrong given that not only individuals but also their
social relationships were all “wrecked”.
2.2. Is Subclinical Pellagra Relevant to Contemporary Disease?
Many poor individuals and groups, even in rich commu-
nities, have low amounts of vitamins in their diet. This
assumes that the recommended daily allowance (RDA) for
vitamins is correct for good health, as opposed to sim-
ply avoiding deﬁciency states. Consequently, subpellagrous
nicotinamide deﬁciency may have lifetime roles in a range
of behavioural traits, neuropsychiatric diseases, and demen-
tias. Dietary choline deﬁciency exacerbates nicotinamide
deﬁciency because metabolism of the two agents is linked;
N-methylnicotinamide blocks choline export [143, 144].
Currently, trials of nicotinamide are underway in AD, stroke
and several other neurological conditions based on the
following [144–182].
(1) The brain uses a lot of energy proportionate to its
weight and glucose and oxygen status and NADH
modulates memory retrieval.
(2) In prospective studies, diets of AD patients were
found to be deﬁcient in nicotinamide premorbidly.
(3) Nicotinamide reduces the accumulation of amyloid
by an eﬀect on secretases and aﬀects the toxic eﬀects
of amyloid on astrocytes by inhibiting PARP and
the NAD synthase nicotinamide mononucleotide
adenylyl transferase (NMNAT) that has protein-
protein chaperone activity and also aﬀects Tau-
induced neurodegeneration by promoting clearance
of hyperphosphorylated Tau oligomers.
(4) In transgenic mice, nicotinamide restores cognitive
deﬁcits with eﬀects on both dendrites and axons and
reduces a phosphospecies of tau which is linked to
microtubule depolymerisation, an eﬀect also seen
following the inhibition of SIRT1, and increases
acetylated alpha-tubulin which is linked to micro-
tubule and tau stability.
(5) In models of AD, overexpression of SIRT1 or PARPs
reduces memory loss and neurodegeneration.
(6) Loss of SIRT1 is associated with the accumulation
of amyloid-beta and hyperphosphorylated tau in the
cortex of AD brains (thought to be compensatory
changes to restore glucose/ketone metabolism).
(7) Recovery of learning and memory has been associ-
ated with chromatin remodeling that happens with
agents that aﬀect SIRT and methyl metabolism and
epigenetic mechanisms seem to be important in AD.
(8) Energy paths involving cAMP and insulin-like
growth factors are involved in memory consolidation
and enhancement.
(9) Dementia is being linked with both being under
and over weight stress and exercise levels and the
metabolic syndrome.
(10) Nicotinamide reduces ischaemic and traumatic brain
damagedirectlyandviaenhancementofthesynthesis
ofNAD:botharecommonadditionalfactorsinmany
forms of dementia.
(11) Redox active methylene blue aﬀects dementia pathol-
ogy and its clinical manifestations.
(12) SIRT I regulates Notch signaling that is involved with
mechanisms of action of mutations in the PSEN1
gene and the proliferation of neural progenitors in
the subventricular zone important in the develop-
ment and evolution of large cortical mantles and
essential for cell speciﬁcation and tissue patterning
(and is involved in human cancer).
(13) NicotinamideandSIRTsareinvolvedwithpromoting
DNA repair particularly in oxidative stress circum-
stances.
(14) Poor diet and chronic diarrhea aﬀecting brain func-
tion may also interact with tradeoﬀsa tg e n e t i ca n d
antagonistic pleiotropic levels. Two copies of the e4
allele of apolipoprotein E lower the incidence of
childhood diarrhea and poor cognitive development
but increase the risk of AD later and appear to be
withinthereachofnaturalselectionasdoothergenes
aﬀecting human longevity.
(15) Lysosomal proteolysis and autophagy require prese-
nilin1andaredisruptedbyAlzheimermutationsand
PD-related mutations.6 Current Gerontology and Geriatrics Research
The neurology of HIV/AIDS, which includes premature
ageing, dementia, and parkinsonism has clinical, patho-
logical and biochemical similarities with pellagra [183]:
many at-risk groups are nicotinamide deﬁcient given that
monophagic corn-based diets are now common in Africa.
Both AIDS suﬀerers and pellagrins get many parasitic infec-
tions which may be dangerous homeostatic responses that
boost NAD(H) in the host when dietary sources of energy
are poor. Tuberculosis, for instance, excretes nicotinamide,
is inhibited by nicotinamide and related compounds such as
Isoniazid and treatment can precipitate pellagra and many
gut infections/parasites break down otherwise indigestible
cellulose, ultimately producing NAD(H) [184]. The HIV
disease marker CD38 is a NADase that regulates intracel-
lular NAD(H), implying disturbed nicotinamide-NAD(H)
metabolism [185]. SIRTs regulate the HIV transactivator Tat,
promoting viral transcription and, through the NF-kappaB
complex, induce T-cell activation particularly in dendritic
cells and there are other links between NAD and the immune
system [186, 187]. In view of the inhibitory eﬀect of nicoti-
namide on SIRT activation and other actions, nicotinamide
ought to be protective in AIDS and other chronic infections
such as TB (that were particularly common in pellagrins)
as an important missing host factor that aﬀects virulence
acting much like a vaccine [188]. Interaction between
symbionts, such as the tuberculosis bacillus, happens by
modulation of immune responses via tryptophan-NAD and
mTOR pathways in dendritic and Th17 cells that have been
under signiﬁcant evolutionary pressures and span immune
and energy pathways, even using ATP as a danger signal
[189–193]. The tryptophan oxidation pathway is particularly
interesting in the current context as it is both the de novo
synthetic pathway for NAD (nicotinamide is like choline a
semivitamin) and the tolerogenic pathway both for microbes
and cancer and contains some potential neurotoxins and is
disturbed in many degenerative diseases: enough NAD from
vitamin B3 sources means less toleration of symbionts and
at the extreme immune intolerance and allergic disorders
[194, 195].
3.HypervitaminosisB3 andCholine
Macronutrients and micronutrients, which include nicoti-
namide, choline, and other methyl sources, may all obey
Bertrand’s rule in that they have an inverted “U” shaped
dose-response curve with toxicity at either extreme, as
was suggested by Waaler regarding increased mortality at
either extreme of weight/height ratio curves [196]. Aﬄuent
populations are exposed to diets with a historically high
caloriﬁc content from reﬁned sugars and fats relative to
energy expenditure. In these populations, energy expen-
diture is relatively low because of limited exercise and
the fact that body heat is maintained through living in
artiﬁcial environments supported by the use of fossil fuels.
Damage is often assumed to occur from the eﬀects of an
obesogenic environment rather than the more direct eﬀect
of disturbed NAD+ :NADH ratios on a variety of dependent
insulin, cortisol and other pathways (also aﬀected by other
bad habits such as smoking and alcohol and stress) with
obesity being an attempt to sequester energy and actively
metabolise nicotinamide (more in keeping with its biological
buﬀering role against starvation, even if it comes at a price)
[197–199]. The relationship of the dose of the hydrogen
source (caloric intake) with the dose of the suppliers of
the carrier (NAD), derived ultimately from nicotinamide
and tryptophan, that must be important for high quality
biologically useful energy, has never been investigated in
detail. Recently the possibility of both too little and too
much choline in diet, modiﬁed by gut ﬂora and genetic
factors, has been raised in the context of vascular disease
[200–202].
Extra choline and other methyl-group sources in diet
from vegetables, meat, milk, and eggs during our evolu-
tion just like other key molecules such as nicotinamide
would have enabled the development of cholinergic, glu-
taminergic, and monoaminergic systems that have actively
evolved in primates and through, for instance, the NADH-
dependent recycling of an essential cofactor, tetrahydro-
biopterin, remain dependent on a good NADH supply for
adequate learning and social and reward behaviour involved
in sustenance and in desiring advance information, often
mediated by dopamine [203–207]. Oxytocin/Vasopressin
pathways are also important for the social interactions that
have been so important to our evolution as are social
substances such as alcohol which are also NAD-dependent,
but all these systems may leave us prone to overindulgence as
circumstances have improved [208–211].
4. An Evolutionary Perspective: Nutritional and
CognitiveTransitions
An evolutionary perspective is warranted, because ageing of
the cerebral cortex and basal ganglia is more prominent in
humans than other primates, who also do not get AD or PD
naturally (even though toxins such as MPTP produce a PD-
like phenotype in the laboratory) and as living to old ages
appears to have arrived late in our evolution and the ageing
process may even ﬁnally stop [212–215]. High exposure to
nicotinamide and choline and other dietary changes that
boosted the overall supply of NAD(P)H may have been
important ingredients of the change in diet of primates from
a grass eating or herbivorous and fruit eating one toward
one containing more starch from tubers and vegetables on to
meat/marrow/brain eating. This triggered the 3-fold growth
over 3 million years of the modern human brain and a high
degree of control over the energy environment [19, 210–
220].
This changed diet towards high quality energy (not just
extra calories from “junk” food, because it combines high
caloriﬁc content with key vitamins such as nicotinamide
and several methyl donors (choline/folate/B12) and essential
amino acids such as tryptophan and phenylalanine and
lipid components such as Omega-3 fatty acids from ﬁsh
[221, 222]). This change ﬁrst happened in NAD(H) source
rich patches of the less arid parts of Africa with repeated
genetic and informatic bottle-necking as our species fol-
lowed energy trails out of Africa and was facilitated byCurrent Gerontology and Geriatrics Research 7
the original invention of tools for butchery and later by
hunting in groups and by the sharing and storing of meat
[221]. Signiﬁcant brain power is necessary for these group
behaviours where individuals specialize and complement
each other and read and anticipate minds of other hunters
and prey and animal assistants with special sensory skills,
and, learn to avoid toxic fauna and ﬁnd natural medication
now in a more seasonal and unpredictable environment.
This brain power enables future-orientated thinking and
delayed reward discounting, so that habitats or relationships
were enhanced and not destroyed for short-term gain
[223–227].
Preadaptations such as endothermy and earlier modiﬁ-
cations of aerobic mitochondrial function enabling proton
leaks and an ample blood ﬂow to the brain to keep it
cool for diurnal and persistent hunting may have helped
[228]. Hominids, from Homo Erectus on, clearly went for
acquiring multiple high energy sources. This enabled the
resultant evolutionary advances via a positive feedback loop
in which increasing energy sources that were easier to chew
allowed the development of larger brains (but small teeth,
masseters and guts), which in turn increased needs, which
led to the search for more and greater energy sources as
niche construction and included the use of exosomatic
energy. However, our brain size may have peaked and
it is smaller than the more carnivorous Neanderthals. In
several species, domestication can lead to striking reductions
in both cortical and striatal volumes surprisingly quickly,
showing that this is a ﬂuid process [229]. The invention of
farming of grain and particularly meat and milk suppliers,
followed by corresponding nutrigenomic innovations, that
facilitated adaptations to new NADH-rich environmental
opportunity, aﬀe c t i n gl a c t o s e( m i l ki sav a l u a b l es o u r c eo f
calories, pathogen-free ﬂuid, and nicotinamide) and alcohol
tolerance, amylase activity and nicotinamide methylation,
happened on multiple occasions and spread fast [227–
230]. This suggests very strong selection pressures working
through both cultural and genetic inheritance, as does
the rapid evolution and diversity of genes involved with
mitochondrial function and glycolytic pathways [231]. This
pressure seems to be every bit as important as mutational
changes in genes directly aﬀecting brain function [232–235].
Bipedal man is thought to have adapted fast, allowing
time and energy to be freed up along with sedentism
that in itself reduced energy expenditure from personal
and child transport and by having a roof over their heads
[236]. The resultant leisure led to the advancement of
interactive minds and a distributed intelligence through
multigenerationalandmultidirectionalsocialstructureswith
critical mass—important for divisions of labour—and a
series of information revolutions that continue to this
day (the “grandmother hypothesis” favours informatic and
energy transfer but grandchildren may equally facilitate
vertical transfers of certain resources such as new language
or technological skills and have been an underrated factor in
social cohesion and longevity).
Along with the social transmission of food preferences
often mediated by acetylcholine release, which reduced the
fear of novel foods, these information revolutions improved
decisions over the trading of and even inheritance patterns
of energy sources and other materials [237, 238]. Intolerance
of a restricted diet based on “fall-back” foods may also
explain our love of ﬂavour and the diﬃculty of ﬁnding single
foods that are particularly protective against diseases rather
than well-balanced omnivorous mixtures. The preference
for a broad diet and the danger inherent in monophagy
are evidenced by the many phenotypes seen with pellagra
[239].
All in turn allowed advanced niche construction and
the development of an energy-rich environment, which was
enhanced by cooking that releases bioavailable nicotinamide
unlike some other vitamins that are destroyed by cooking.
Combined with other uses of ﬁre, this enabled a more
ecologically diverse and productive environment, such as
increasing the number of available herbivores, so that less
energy was expended on hunting but with greater certainty
of success. Early man, through some degree of social
independence and a consciousness, could move to brand
new pastures or construct pastures new through planning,
imagination, and innovation [240, 241].
5. More Recent History: The Neolithic and the
Columbian Exchange
The history of maize, the crop that triggered pellagra, is a
good example of coevolution because it is now dependent
upon us for its sexual reproduction and we are very depen-
dent on it as an energy source. The initial cultural spread of
maize is one of the best examples of diﬀusion of innovation,
whichsometimeswentwrongfromlackofattentiontodetail.
When it was imported to the southeastern states around
2000BC and later Europe from central Mexico as part of
the “Columbian exchange”, it was improperly cooked and
not combined with beans and squash or adequate meat.
Maize is popular as it is a C4 plant with very eﬃcient
photosynthesis particularly when water is at a premium.
New breeds underpin a large section of modern agribusiness.
Together with other technoinnovations they have raised
production from 1Kg per hour on a Kenyan farm to 1000Kg
per hour on farms in Iowa [242].
Maintaining and enhancing the supply of high quality
components, such as meat and milk, during the original
agricultural revolution/Neolithic Demographic transition
and over recent centuries has not always been easy and
has caused tradeoﬀs between high population growth and
health [243–246]. At times, micronutrient shortage such as
lack of nicotinamide would have been more of a problem
than shortage of calories and may be a mirror image of the
much more recent contemporary demographic transition
in Western industrialized societies. Population growth may
have had a large part to play in the chronic malnutrition
that has stunted growth and led populations to be prone
to acute infection (which stresses the NADH axis); it has
coincidedwiththecoevolutionofchronicinfections(e.g.,TB
that excretes nicotinamide) and malaria (that aﬀects NADH
status, as do malaria resistance genes such as those causing
G-6PD deﬁciency).8 Current Gerontology and Geriatrics Research
6. Afﬂuence
A doubling of life span has occurred in many economies
over the last 200 years, largely from the reduction in
what were then common infectious diseases. Better diet
has increased resistance to acute infections that compete
for NAD resources as do their toxins. In the case of
the so-called “infectious chronic unconquerables”, such as
malaria and TB, there appears to be an immunological
stand-oﬀ in which a degree of tolerance may have been
traded for an increased supply of an essential nutrient.
Many apparently healthy carriers, which were present in the
dietary deﬁcient population, literally disappeared as dietary
standards improved in Europe and the USA. Thus, with
the increasing quality of diet, symbionts become no longer
necessary to supplement diet and the immune system can
revert from controlling the population size of a mutualist
parasite to trying to kill every invader. Recent information
on the role of NAD modulating innate immunity suggests
complex energy-centred interactions between neuronal and
immunological systems. Contextually useful organisms (as
seen in cases of pellagra) depend on ecological factors such
asdietratherthangeographyorphylogeneticconsiderations,
and on a good diet with changed prebiotic composition
may no longer be advantageous. With the improved western
diet, the immunological reaction to the formerly “useful”
and actively welcomed biotic antigens concerned may be
“confused” and may extend through molecular mimicry and
nutrition-related signals to other antigens, thus setting oﬀ
abnormal inﬂammatory and autoimmune reactions includ-
ing to foods and pollens (that contain NAD(P)H oxidases).
This is a diﬀerent explanation to the more restricted hygiene
hypothesis where lack of exposure rather than actively
shunning “old friends” is postulated to cause immunological
hyperreactivity [247–251].
Here we suggest the possibility that a hypervitaminosis
B3 state, with both nicotinamide and N-methylnicotinamide
having an optimal range, resulting from a western diet over-
rich in meat and vitamin supplements working alongside
caloriﬁc excesses may be implicated in other modern disease
phenomena. Meat eating is preferred where it is available,
though during pregnancy it is a common dietary aversion,
suggesting that it can be toxic in early development as does
the presence of the detoxiﬁcation enzyme, NNMT and evi-
dence of acute toxicity with nicotinamide overdose and wor-
riesaboutredmeatbeingariskfactorforsomecancers[252–
254]. Nicotinamide exposure can be high, in excess of ﬁve
times the recommended daily amount (15mg/day) where
diet has both cereals and “high energy” drinks supplemented
with the vitamin and where there is an abundance of cheap
meat and milk. This chronic overload can be envisioned as
working through unbalancing NAD(H)-dependent systems,
including SIRTs and PARPs or dehydrogenase pathways (for
instance in cortisol metabolism), and through the direct
eﬀects of nicotinamide or N-methylated metabolites. NAD+
is the substrate for SIRTs and nicotinamide is an inhibitor,
so dietary levels of NAD(H) precursors could act as both
positive and negative inﬂuences on such systems. In the
case of nicotinamide, dietary inputs are modulated in part
by genetic determination of NNMT levels, with 24% of
the population being high expressors. Nongenetic factors
also modulate expression of the enzyme. These include
nicotinamide itself, stress and the demands imposed on
NAD(H) availability by growth, tissue repair and exercise.
Interestingly, NNMT and other components of NAD(H)
pathways are markedly induced in a variety of currently
common cancers as well as in the metabolic syndrome,
obesity, PD and autism [255–262].
An animal model of toxicity from excess dietary nicoti-
namide has been reported. In this model, dopaminergic
neurons were damaged and locomotor activity was reduced.
In addition, this model responded to L-DOPA [263]. In
other models, nicotinamide and novel derivatives such as N-
Nicotinoyl dopamine can reduce melanin as happens in PD
[264, 265].
OneconsequenceofNNMTinductionandothermethyl-
transferase reactions is a depletion of methyl stores and S-
adenosylmethionine (SAM) that is ultimately dependent on
an adequate dietary supply from expensive vegetables and
meat rather than cheaper cereals such as corn (banned in
19th century France as unﬁt for human consumption, thus
eliminating pellagra at a stroke: a lesson for modern Africa)
[266]. Depletion of available methyl groups, whether from
a poor diet or one with excessive nicotinamide, may be a
common cause of epigenetic phenomena given the marked
inﬂuence methylation has on gene expression in pluripotent
and diﬀerentiated cells that maintain cellular identity [265].
The methylome is an important mediator of information
and modiﬁes gene transcription and translation including
riboswitches aﬀecting RNA metabolism and in toxicology
pathways in concert with NAD and ATP and all appears to
be involved in a number of diseases seen within the pellagra
phenotype such as cancer and motor neurone disease [267–
272]. A major role for the methylome is well accepted for
many cancers and their related epimutations sometimes
workinginconcertwithDNAsequencemutationsintumour
suppressor and DNA repair genes and may well be modi-
ﬁable by diet [273–277]. There may be several mechanisms
whereby such metabolic programming can be inherited and
aﬀect oﬀspring [278].
7. A Deep History of Hydrogen and
Hydrogen Symbioses: Origin of Cooperative
Species[279–281]
Life without hydrogen is impossible, whether free or bound
with NAD(P) as energy or with oxygen as a solvent.
The sun burns hydrogen in a fusion reaction and emits
light energy. Early life chemo-litho-autotrophs used redox
gradients including hydrogen as the electron donor and
then the earliest animals developed symbiotic relationships
with bacteria that produced hydrogen and the invention of
photosynthesis split water to produce hydrogen as NADPH
and oxygen (earlier forms split H2S). Hydrogen can escape
from the earth and led to the great oxidation events and
an oxygen atmosphere that along with important symbiotic
acquisitions involving chloroplasts, hydrogenosomes, andCurrent Gerontology and Geriatrics Research 9
mitochondria allowed the evolution of complex plants and
the rise of an animal kingdom that eats hydrogen sources or
has gut symbionts that produce hydrogen equivalents from
otherwise indigestible foods. Too much hydrogen escape
from splitting of water by radiation in the upper atmosphere
creates “runaway greenhouse” eﬀects that are incompatible
with life and may have happened on other planets and
could happen here. Early mammalian inventions that would
increase hydrogen and nicotinamide sources include pla-
cental and milk feeding. Healthy energy ecosystems reduce
poverty and underpin healthy interactive economies: and
even though modern economies appear to move away from
a primary reliance on natural capital and capturing solar
energy, we all need to eat well to stay healthy and need to
appreciate the real source of our prosperity and the need to
avoid food crises worldwide.
8. Longevity andNutritionalBalance
The NAD(H) energy path and NAD consuming hubs are
involved in many key cellular processes and in the regulation
of food intake and the phenomenon of caloric restriction
and hormesis (that which does not kill you, whether diet,
toxin, emotional, acute infectious or traumatic stress, makes
you stronger) which are implicated in many diseases of
ageing [282–302]. These hubs are amenable to therapeutic
intervention and may unwittingly have contributed by a
better overall diet and energy budgets to recent increases
in longevity in aﬄuent countries (Figure 2). Age-related
changes in NAD/NADH ratios have been noted and a world
where NAD is central postulated [303, 304]. Placebo eﬀects
that are so prominent in man also have been linked to energy
pathways and are particularly eﬀective when the energy
future is perceived as healthy, allowing energy to be invested
in healing rather than ﬁre ﬁghting [305]. Endocannaboids
that depend upon the organisms energy status may translate
food availability into fundamental choices about develop-
ment which aﬀect lifespan, and some addictions that were
commoninpellagrinssuchasNicotinearealsocloselylinked
to energy pathways. Caloric restriction hints at the need
for a nutritional stoichiometry to balance energy demand
and supply throughout life. It is associated with telomeric
stability and increased SIRT 1 activity stabilising PGC-1
and results in increased mitochondrial biogenesis, metabolic
function, and the deacetylation and inactivation p53.
This balance may be more about NAD+ :NADH ratios than
caloriesperse,whichmayexplaintheperplexingandcontra-
dictory role of NAD-consumer agonists (such as resveratrol)
and antagonists in disease models. SIRT1 knockouts show
widespread p53 activation and shortened life expectancy
[306]. Increased longevity as a result of caloric restriction
and related genetic models ﬁts with abundant evidence that
nicotinamide is involved in neuroprotection [307–318]. The
damaging eﬀe c t so ft o ol o wad o s ea r eam a t t e ro fh i s t o r i c a l
record. Evidence is emerging on excessive intake of the
vitamin [319, 320]. Nicotinamide’s actions may be double-
edged as although it is eﬃcacious in a wide range of current
insults and pathologies too much may be as harmful as too
little.
Links between nicotinamide, acetyl and methyl metab-
olism and epigenetic phenomena are strong [319, 320].
Other recently studied famines such as the Dutch hunger
winter of 1944-45 and the Chinese famine of 1958–61
had marked long-term and transgenerational eﬀects on
health such as the risk of the metabolic syndrome but
also psychiatric and antisocial behaviours working through
epigenetic mechanisms: those aﬀected would have been
NAD(H)-deﬁcient with an element of pellagra [321, 322].
Optimising choline and other aspects of methyl metabolism
in embryonic life improves brain development and strik-
ingly reduces age-related declines, perhaps through reducing
epigenetic instability. Epigenomes, which may be marked
by dietary, emotional, and intellectual experiences working
through neuroendocrine stress pathways that themselves
are redox and energy-regulated and implicated with many
“modern” diseases, can be assimilated into the germline
and are unstable, creating somatic epimutations during
mitoses,someofwhichmayberesistanttoerasure.Surviving
epigenetic imprints may be the missing transgenerational
elements, along with nonshared environments (merging
nature and nurture), causing both familial clustering and
sporadic cases in diseases such as AD and PD. Twin studies
showlowconcordanceinADandPD,therebydemonstrating
the importance of environmental dynamics and chance
epigenetic drift over lifetimes [323].
9.Development toDecline:Managing
Metabolic Expectations
Within the context of lifetime availability of NAD(H), where
in adult life the net free energy or the availability of methyl
groups is greater or lesser than that in early life or expected a
prioribythegenomeoftheindividual,animbalancebetween
(epi)genetic-primed protein inductions and nicotinamide
may occur if circumstance overcome tastes, habits, and
addictions that attempt to stabilise intake. This imbalance is
more nuanced than might be expected and not simply due
to the fact that modern diets are mismatched with genetic
“thrifty” gene hangovers from the Pleistocene [324]. Our
evolutionary history of extreme ﬂuctuations in meat intake
from low to high as hunter-gatherers to patchy and still in
transition is likely to be more relevant. Nutrigenomic and
informatic adaptations and changes in tradeoﬀs resulting
fromknowingthattheenergyfutureisoftenmorelikelytobe
benign have occurred over the last 100,000 years and during
individuals lifetimes. Low levels of nicotinamide and choline
in early life adversely aﬀect neonatal brain development
and later degeneration [325]. Low NAD(H) levels in the
foetal/neonatal period could result in a phenotype which
could be reinforced by low levels through life, giving
rise to poor brain development and function. High early
levels could lead to good brain development (“luxury”
phenotype) but a drop in the supply later in life, even to
average levels when NNMT, the catabolic enzyme, has been
induced, could trigger intracellular pellagra. If the NAD(H)
and nicotinamide supply is superabundant throughout, life
toxicity might result from excessive N-methyl-nicotinamide,
a MPTP lookalike (Figure 3). This is plausible because10 Current Gerontology and Geriatrics Research
Nicotinamide homeostasis throughout life may determine ageing and 
neurodegenerative disease in man
Foetal/neonatal life
Diet
NAD(H) and ATP 
NNMT expression
genomic polymorphisms + 
epigenetic/metabolic imprinting
Good
Poor
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Optimal
Low
Low
Low
Classic PD 
Longevity
PD/dementia 
(pellagra-like)
Premature 
senescence
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Postneonatal niacin dietary intake
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Figure3:NAD(H)availabilityiskeytogoodbrainevolutionanddevelopment.Aninherentweaklinkispoorsupplyorapotentialimbalance
between induction of NNMT and nicotinamide and choline intake in early and later life with a risk of late degenerations such as Alzheimer’s
and Parkinson’s disease. Overinduction of NNMT by nicotinamide could paradoxically cause intracellular pellagra perhaps explaining why
nicotinamide can appear to help short-term even though nicotinamide may be a long-term toxin. In addition, poor diet or induction of
NNMT disturbs the methylome and the epigenome creating cancer promoting epimutations.
nicotinamide and redox status have marked morphogenic
eﬀects that instruct internally secreted morphogens which
regulate all phases of neuronal development and in eﬀect
brainevolution[326–328].Theeﬀectscanbecomepatholog-
ical when unexpected energy circumstances are encountered,
as seen with metabolic syndrome, and we propose neurolog-
ical disease [329].
10.MetabolicFields
Accumulating evidence points to the probability that ageing
diseases such as AD, PD, cancers, and metabolic diseases
originate in mitochondrial depolarisations and uncouplings
with disturbed electron-proton ﬂows as “protonopathies”
and have consequent eﬀects on ATP [330–333]. A unifying
explanation imagines abnormally spreading metabolic ﬁelds,
if the challenges of balancing NADH- dependent energy
supply and demand and the need for optimal methyl group
availability that arises during growth, reproduction, exercise,
and tissue repair are not met; most cancers, for instance
are demethylated and have changed their energy metabolism
proﬁle even in precancerous stages [334]. These challenges
could happen at the same stage of life in diverse species,
explaining similar incidences of cancer and degeneration
despite large variations in numbers of cells/body size and
longevity that are hard to explain on a somatic mutational
or purely immunological basis which may be secondary
or compounding phenomena [335]. Reactions to stabilize
metabolism by excreting NAD(P)H (essentially a waste
product not a source of energy in cells using anaerobic
metabolism) or other reducing equivalents (e.g., lactate),
suchasautocarnivory/autophagy/apoptosisandtheWarburg
eﬀect (such that both the oxic and, of course, the anoxic
portions of the tumor are both fermenting) could spread like
awave:asdotheirpathologicalcorrelates,whetherdegenera-
tions, infections, or cancers. NAD metabolizing ectoenzymes
and salvage pathways appear to be important in shaping
tumor-hostinteractionswithmitochondrialpathwaysaﬀect-
ing whether or not cancer cells live or are primed for
death [255, 336–344] .N N M Ta c t i v i t ya ﬀects proliferation
of cancer cells, aﬀects radiation sensitivity, and alters free
radical production; nicotinamide aﬀects genomic instability
andcancercellseattryptophan[340,345,346].Theseheavily
involved pathways have opened therapeutic possibilities for
several tumours including glioblastoma where the impor-
tance of mitochondrial dynamics is increasingly recognised
[347]. In cancer cells many germline and somatic mutations
continue to evolve as cancer spreads, for example, in p53
and relevant receptors, such as those for steroids and growth
factor signals. Thus glucose uptake and mitochondrial and
isocitrate and phosphoglycerate dehydrogenases and pyru-
vate kinases are aﬀected, allowing multiple switches from
oxidative metabolism to net NAD(P)H production aﬀecting
both energetic and redox buﬀering/antioxidant capacity
[262, 348–355]. The paradox here if solely seen from the
cancers point of view, rather than viewing this as a pseudo-
symbiosis, is that the growing tissue is wasting energy and
the argument that it gets ATP faster through glycolysis is
weak [356]. Cancers cannot always be eliminated and often
recur (though occasionally spontaneously remit) or a second
cancer develops, suggesting that the basic problem is not
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cells (which may however temporarily improve the local
energy environment by releasing ATP and its precursors).
Foetal implants develop PD pathology, illustrating the
point that the niche microenvironment is the key [357–363].
Stem cell implants in PD and other conditions survive and
connect but form strange lesions and connections suggesting
that lack of stem cells is not the real deﬁcit. Rather stem-
cell-based therapy from the haematological transplant to
those for other organs involves the eﬄux of NAD and ATP
into the extracellular space or autocrine induction of NAD
release activating purinergic and calcium pathways aﬀecting
growth-supporting and antiapoptotic activities relevant to
their therapeutic eﬀects [364]. Parabiotic fusions of young
environments rejuvenate cells, even those expressing pro-
cancerous somatic mutations or destined for autophagy
[365] and changing the ageing milieu, alter neurogenesis
and improves cognitive function. Stem cell fates toward both
normal and abnormal diﬀerentiation or dediﬀerentiation
depend on their microenvironment and stochastic factors,
and even cells that are already cancerous can be induced
to behave normally [366–369]. Protein folding and the
function of amyloid/synuclein/prion proteins and ionic and
neurotransmitter gradients are exquisitely sensitive to energy
landscapes, as are NAD(H)-consumer linked DNA repairs.
Consequently, all these phenomena, when abnormal, may
be secondary and late eﬀects of abnormal NAD(H) ratios
and methylation status aﬀecting epigenomic phenotypic
plasticity.
11. Regeneration and Degeneration on Purpose
In complex organisms stem-cell-driven regeneration, which
could compensate for long-term damage that is beyond
repair, is suppressed particularly in the CNS, whilst dying
cells from traumatic injury releasing NADH equivalents may
be a potent stimulus for regeneration in other tissues and
simpler organisms [370]. This apparent design failure, which
is actively pursued by complex organisms, may be rooted
in energy allocation models, that is, in tradeoﬀs that favour
building spare capacity during development. Spare capacity
when young, which can be coopted as an exaptation for early
in life innovative thinking about the environment, may be
evolutionarily more advantageous than maintaining, at high
cost, regenerative machinery permanently on stand-by that
may never get used.
The brain functions within the constraints of an energy
(ATP) budget, with high levels of energy used to process
information from the environment via action potentials and
less energy intensive metabolic processes used to recycle
neurotransmitters [371–374]. There is evidence that this
b u d g e te v o l v e dt op e r m i to t h e rt r a d e o ﬀs allowing neuronal
energy costs to remain low while still allowing the organism
to gather all required information. In environments where
certain sensory information is not needed, evolution has led
to the loss of superﬂuous sensory systems. This responsive
and adaptable evolutionary process can also lead to the
addition of sensory systems as required by changing envi-
ronments. Such additions and deletions develop as a result
of an advantageous cost/beneﬁt analysis by the evolving
organism responding to changing environments and to learn
for speciﬁc tasks as well as for general intelligence [375].
Poor development from poor early energy circumstances
and loss of reserve capacity would be expected to cause
late problems, as suspected with AD. Nevertheless, continual
regeneration and selection of circuits that are using energy
are constantly occurring by altering mitochondrial and SIRT
function, and bioelectric free energy and proton ﬁelds and
ﬂuxes, that inﬂuence positional memory and regeneration
of even complex structures such as the spinal cord (giving
hope that improving the NAD(H) and methyl environment
is never too late) [7, 376–378].
12.EnergyCircuitsCanBreakdown
We live in a complex habitat and an energy and informatic
subsistence environment largely of our own making that has
driven our brain and behaviour patterns to ecological ratio-
nality, in order to cope with being far from thermodynamic
equilibrium, with strong positive feed-forward decision-
making and negative feedback homeostatic mechanisms that
drive progress. Less fortunately disease phenotypes from
the cancerous to the neuropsychiatric happen when it goes
wrong, as happened in the case of pellagra. Pellagra like
most famines was not wholly caused by natural disasters but
man-made collapses at a series of hierarchical levels from the
social to the subcellular. Ever since Homo Erectus, our genus
has been addicted to acquiring more and more energy, ﬁrst
as NADH and then harnessing all forms of energy, with a
push from coping with poor energy environments and a pull
from using excess energy to best advantage through the use
of our collective imagination and each other: much current
intellectual eﬀort is currently expended on discovering new
sources of energy especially those based on hydrogen [379,
380]( Table 1). Many memes/ideas are generated and their
survival may often have been dependent upon whether they
contain energy-useful ideas, with logic systems working at
biological and behavioral levels building on simpler circuits
suchastheiconictranscriptionalregulationofthelacoperon
in response to changing energy sources. This requires a high
quality diet and gut symbionts forming superorganisms with
extended metabolisms that are not simply divided by skin or
skullfromtheworldbutarecomplementarysystemsthatstill
have fault lines that can breakdown. Self, as usually deﬁned
by the immunologists, is misleading, and more modern
views on metagenomes are closer to the mark and, like the
psychologist William James, deﬁne self as “all a man can
call his” and includes his sources of energy and information
[381].
Despite consuming a high proportion of the body’s
energy, brains are eﬃcient (Watson, IBM’s latest AI answer
machine runs on 100Kw compared with 100w for a
brain) and lose functions no longer used, suggesting strict
constraints on bioenergy allowing the brain to continually
evolve along with the changing environment, with consider-
able potential for human enhancement if the environment
improves [382]. Enrichment of the cell’s microenvironmen-
tal energy ecosystem and a “use it or lose it” strategy12 Current Gerontology and Geriatrics Research
Table 1: Three worlds that interact are largely human thermodynamic and cognitive niche constructions that are all heritable making
us codirectors of our own and our collaborators evolution. There is a cost to this cumulative evolution that may include hypo- and
hypervitaminosis, energy, and informatic states.
Thermodynamic and material Personal Information and society
Omnivorous diet Conscious perception Divisions of labour
Trading symbionts Empathy Trading
Shelter/clothes Mental time travel Information stores
Know-how
Language
Nutrigenomics
Immunogenomics
Neuro/endocrine homeostasis
Surplus energy for innovation of tools and technology and further harnessing of energy.
leading to energy ﬂow may be key to improvements in
the longevity of many cell types and in prompting neural
stem cells, “hungry for action”, to divide. Maintaining opti-
mal NADH:NAD+ ratios and methylation status through
dynamicenergybudgetsineverycompartmentisacontinual
challenge which is awe-inspiring in its complexity. Neverthe-
less, such considerations are necessary for every single cell if
theyaretoavoiddeathorcancerouschangeandmaybeaided
by quantum eﬀects on the distribution of energy [383]. High
energy circuits and electrical waves, such as gamma oscil-
lations, are needed for intellectual hippocampal and motor
programmes that require strong functional performance of
mitochondria and particularly need the pyramidal neurones
that take a big hit in pellagra [384, 385]. These circuits are
synchronous with circadian NAD(H)-dependent informatic
rhythms between individuals and their diets, symbionts
and social relationships and beliefs, some mediated by
hormones such as oxytocin and neurotransmitters such as
dopamine. Sleep gives time for synaptic normalization after
dealing with ever-changing environments and unsustainable
consumption of energy with saturated abilities to learn
as environmentally cued memory and free-will decision
making, over and above reﬂex preactivation of volition,
require particularly high energy levels: these are functions
hit early in cortical and basal ganglia degenerations some of
which compensate by the patients developing a sweet tooth
or otherwise modify energy intake or expenditure as part of
the symptoms or attempts at treatment [386–396].
These environmentally coupled systems, largely of our
own making to keep energy ﬂowing and balancing excitatory
and inhibitory circuits, can get decoupled with energy or
informatic under or overload (“rewired and running hot”)
and may be hit preferentially in PD and AD and other
diseases peculiar to Homo sapiens, such as depression and
psychoses where nicotinamide aberrations have long been
suspected [358, 359]. We urgently need to improve our
abilities to measure or image suitable NADH supplies in
a series of human habitats on the outsides of our Russian
Doll Redox arrangement and NAD(P)H/NAD(P)+ ratios
in every internal compartment, cell type and organelle as
early warning systems to intervene and avoid pathology even
getting started.
13. Conclusion
Classical pellagra is an archetypal energy and NAD supply-
side premature ageing disease, with excessive use of sym-
bionts and degenerative pathology, that has been cured but
we have never checked to see whether subpellagrous NADH
deﬁciency has been eliminated. Sub pellagrous NAD deﬁ-
ciency may be a man-made socioeconomic “place” disease
that rears its head episodically as a “time” disease triggering
age-relatedinfections,degenerations,andcancers[397].This
type of socioeconomic illness does not naturally trigger an
empathetic response reducing the chances of resolving the
situation [398]. Interactions with other vitamins may be
important either with deﬁcits or excesses as we have implied
forcholine,andforexample,thecombinationoflowvitamin
D intake with genetic predisposing defects, and, NAD
supplies, and, altered relationships with microorganisms
triggering autoimmune demyelination may be important
in the pathogenesis of multiple sclerosis [399, 400]. Intra-
cellular pellagra may also be caused by other mechanisms
such as high NAD expenditure after physical, emotional,
or chemical toxic stress or acute infection or inadvertent
removal of key symbionts, such as after antibiotic use, or
mutations that impair autophagosome functions such that
at some times or for some people the dose may need to
be higher than usually recommended. Stress from loss of
relative status is a powerful driver of ill health and primates
including man revert to a high glucose and low nicoti-
namide diet or addictive behaviours that as with stress also
induce NNMT that will further lower nicotinamide levels
[401, 402].
One should not, on the other hand, expose populations
to “too much of a good thing” with excessive supplies of
nicotinamide or choline or calories and thereby perturb
NAD:NADH ratios in favour of NADH, creating a mirror
image of pellagra, perhaps with an equally broad phenotype
[403].Moderndiseasepatternsmaybecontemporarymirror
images of the Neolithic meat transition when with less
meat fertility rose but so did disease reducing longevity,
whereas now as meat eating is on the increase longevity
is increasing with fertility dropping and diﬀerent chronic
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Poor worldwide distribution of NAD(H) supplies makes
little sense if oversupply is dangerous, particularly if under-
supply is not only dangerous to those aﬀected but leads to
new symbionts or drug resistant microbes aided and abetted
by the host in metabolic desperation that can then infect
others who are more aﬄuent and cause potentially epidemic
pathology [403]. Our current behaviour that does not deal
with this urgently “altruistically” may need the insight that
as group sizes were enlarged we moved away from our
hunter-gathererrootsofanegalitariannormandasharingof
nicotinamide and methyl group rich meat. “Stinginess” may
date from when the natural meat supply deteriorated and
meat and the considerable wherewithal to produce it became
treated as property. Fighting and migrating were preferred
overstarving,andtradingmayhavepromotedspecialisation,
competition, and inequality including of access to meat
[404]. Resource allocation both of food and of medicines
is culturally driven with a tension as to whether those
that earn the most or those with the greatest need are
given preference. The former is the usual modern default
option but is a cultural “homo-economicus” evolutionary
trapthatneedstobeconsciouslyandsociallycorrected[405–
407]. Fairer access to high quality energy sources allows
all people the choice of moderation and a Hippocratic
style diet and exercise regimen, and, access to parallel drug
developments which have hormetic and preconditioning
eﬀects: that test the energy axis, induce autophagy and
unfolded protein targeting and endoplasmic reticulum stress
responses to recycle protein debris, thus preventing and
“vaccinating”againstdisease[408–410].Newtreatmentsthat
quickly supply energy, or save energy by inducing artiﬁcial
hibernation, if employed after an unexpected insult such as
trauma, and allow natural healing to take place, may also
work best [411].
Humans have been exploring ways of preventing can-
cer and degeneration for decades whereas evolution has
coped with episodes of NAD(H) deﬁciency and excess
for several billion years. Now it may be time to learn
lessons from the experts and ﬁnd a Goldilocks energy-
methylome-informatic-economy that matches supply and
demand throughout life. Fewer energy tradeoﬀs or faulty
signals may avoid lost robustness, shorter lives and loss of
a ﬁtness trait such as intellectual or physical capacity as seen
withthedegenerativeADandPDortheproliferativecancers,
inﬂammatory and allergic diseases.
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